A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Saved in:
| Title: | A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Bhai S; University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Neuromuscular Center, Institute for Exercise and Environmental Medicine, Texas Health Dallas, Dallas, Texas, USA., Levine T; Honor Health, Scottsdale, Arizona, USA., Moore D; Calico Consulting, Livermore, California, USA., Bowser R; Barrow Neurological Institute, Phoenix, Arizona, USA., Heim AJ; University of Kansas Medical Center, Kansas City, Kansas, USA., Walsh M; University of Kansas Medical Center, Kansas City, Kansas, USA., Shibani A; Nerve and Muscle Center of Texas, Houston, Texas, USA., Simmons Z; Penn State Hershey Medical Center, Hershey, Pennsylvania, USA., Grogan J; Penn State Hershey Medical Center, Hershey, Pennsylvania, USA., Goyal NA; University of California, Irvine, California, USA., Govindarajan R; University of Missouri, Columbia, Missouri, USA., Hussain Y; Austin Neuromuscular Center, Austin, Texas, USA.; University of Texas Dell Medical School, Austin, Texas, USA., Papsdorf T; Access TeleCare, Dallas, Texas, USA., Schwasinger-Schmidt T; University of Kansas School of Medicine-Wichita, Wichita, Kansas, USA., Olney N; Providence Brain and Spine Institute, Portland, Oregon, USA., Goslin K; Providence Brain and Spine Institute, Portland, Oregon, USA., Pulley M; University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA., Kasarskis E; University of Kentucky, Lexington, Kentucky, USA., Weiss M; University of Washington, Seattle, Washington, USA., Katz SW; Syneos Health, Morrisville, North Carolina, USA., Moser S; University of Missouri, Columbia, Missouri, USA., Jabari D; Cedars-Sinai Medical Center, Los Angeles, California, USA., Jawdat O; University of Kansas Medical Center, Kansas City, Kansas, USA., Statland J; University of Kansas Medical Center, Kansas City, Kansas, USA., Dimachkie MM; University of Kansas Medical Center, Kansas City, Kansas, USA., Barohn R; University of Missouri, Columbia, Missouri, USA. |
| Corporate Authors: | Neuromuscular Study Group and Western ALS Consortium Memantine ALS Study Group |
| Source: | Muscle & nerve [Muscle Nerve] 2025 Jan; Vol. 71 (1), pp. 63-72. Date of Electronic Publication: 2024 Nov 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 7803146 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4598 (Electronic) Linking ISSN: 0148639X NLM ISO Abbreviation: Muscle Nerve Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-4598 |
|---|---|
| DOI: | 10.1002/mus.28287 |
